Trial NCT00946712

View at ClinicalTrials.gov 
Org. Study IDs: S0819
Secondary IDs: CDR0000649817 NCI-2009-01664 S0819 U10CA032102 U10CA180888

Last trial update was posted on 2023-05-23

MeSH Interventions

Albumin-Bound Paclitaxel Antibodies Antibodies, Monoclonal Antineoplastic Agents, Immunological Bevacizumab Carboplatin Cetuximab Endothelial Growth Factors Immunoglobulin G Immunoglobulins Paclitaxel

MeSH Conditions

Adenocarcinoma Adenocarcinoma of Lung Carcinoma Lung Neoplasms Recurrence

Other Conditions

Recurrent Large Cell Lung Carcinoma Recurrent Lung Adenocarcinoma Recurrent Squamous Cell Lung Carcinoma Stage IV Large Cell Lung Carcinoma Stage IV Lung Adenocarcinoma Stage IV Squamous Cell Lung Carcinoma

Stopping Reasons

terminated at pre-planned futility analysis

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID